February 17, 2026
TOPLINE: In patients with suspected autoinflammation, whole exome sequencing (WES) achieved a 19.5% diagnostic yield, compared with 14.9% with targeted gene panel testing for autoinflammatory disease […]
February 16, 2026
TOPLINE: Patients with systemic lupus erythematosus (SLE) who received belimumab monotherapy had remission rates, Lupus Low Disease Activity State (LLDAS) attainment, and flare rates comparable to […]
February 16, 2026
TOPLINE: More than 80% of patients with newly diagnosed rheumatoid arthritis (RA) discontinued prednisolone after 7 weeks of bridging therapy alongside methotrexate monotherapy. A subset of […]
February 13, 2026
Rheumatologists welcomed provisions in a recently enacted US federal spending package that extended some telehealth coverage and may eventually lower drug prices, but they found mixed […]
February 13, 2026
Chimeric antigen receptor (CAR) T-cell therapy has cleared another hurdle on the path to potentially becoming a viable treatment option for people with severe autoimmune diseases, […]
February 12, 2026
TOPLINE: In patients with proliferative lupus nephritis, belimumab combined with standard therapy improved renal response rates, reduced glucocorticoid use over 12 months, and showed a favorable […]
July 4, 2025
TOPLINE: Remote monitoring and patient-initiated care matched usual care in maintaining low disease activity in patients with axial spondyloarthritis (axSpA) on stable TNF inhibitor therapy. METHODOLOGY: […]
July 3, 2025
TOPLINE: Abatacept outperformed hydroxychloroquine (HCQ) in preventing patients with palindromic rheumatism (PR) from progressing to rheumatoid arthritis (RA). METHODOLOGY: Researchers randomly assigned 70 individuals with PR […]
July 3, 2025
Despite the rising incidence of rheumatoid arthritis (RA), extra-articular manifestations have become rare in the era of modern treat-to-target therapy. However, they still present clinical challenges […]